Pfizer Puts Lipitor Site Up For Sale as Patent Expiration Causes Over-Capacity
Lower sales of off-patent former blockbuster Lipitor have prompted Pfizer to try and sell off its third Irish API plant in as many years.
Archives for May 15, 2013
UK ‘animal research’ labelling plan may have unintended consequences says Cyprotex
Proposed UK “animal research” labelling laws may backfire if improvements in culture-based toxicology testing continue, according to in vitro CRO Cyprotex.
Quintiles Signs Exclusive Development Deal with Merck Days After $1B IPO
Just days after raising more than $1B in its IPO, Quintiles announced Wednesday it signed a five-year clinical development agreement with Merck Serono.
US House Committee Advances Track-and-Trace Legislation
The US House Energy & Commerce Committee on Wednesday advanced a bill to further secure the US prescription drug supply chain, though it stops short of mandating unit-level, electronic tracking and tracing of drugs.
UK Animal Research Labelling Plan Must Not Put Patients Off Treatment, Says ABPI
New UK proposals to label all drugs as “produced as a result of research on animals” have met with muted response from pharmaceutical industry group, the ABPI.
PPD Subsidiary Expands Biopharma Services with New China Lab
BioDuro opened a new laboratory in Shanghai, China on Wednesday to offer a range of customized biopharma services for its Asia Pacific clients.
Dispatches from Vitafoods Europe 2013
Chewing gum developed to battle common cold
Private label gum maker Fertin Pharma has developed an immunity chewing gum that it claims can help guard against the common cold.